{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:54:08Z","timestamp":1786650848227,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0253-7613.125159","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T04:39:29Z","timestamp":1389847169000},"page":"18","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of clinical outcomes and prescribing behavior among inpatients with severe preeclampsia and eclampsia: An Indian experience"],"prefix":"10.4103","volume":"46","author":[{"given":"Dipika","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefalika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BL","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.125159-1","first-page":"S1","volume-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.SOGC Clinical Practice Guideline","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.4103\/0253-7613.125159-2","first-page":"e13","volume-title":", CHIPS Pilot Trial Collaborative Group.The control of hypertension in pregnancy study pilot trial","author":"Magee","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.4103\/0253-7613.125159-3","first-page":"335","volume-title":"Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy","author":"Kacew","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.125159-4","first-page":"129","volume-title":"Ensuring the safe and effective use of medications during pregnancy: Planning and prevention through preconception care","author":"Cragan","year":"2006","journal-title":"Matern Child Health J"},{"key":"key-10.4103\/0253-7613.125159-5","first-page":"104","volume-title":"Medication use during pregnancy and lactation: An urgent call for public health action","author":"Lagoy","year":"2005","journal-title":"J Womens Health"},{"key":"key-10.4103\/0253-7613.125159-6","unstructured":"Introduction to Drug Utilization Research [Internet] 2003 [cited 2013 Dec 12]. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacology. Geneva: World Health Organization, 2003.. Available from: http:\/\/www.whocc.no\/filearchive\/publications\/drug_utilization_research.pdf"},{"key":"key-10.4103\/0253-7613.125159-7","first-page":"159","volume-title":"American college of obstetrics and gynaecology (ACOG) practice bulletin Number 33, 2002","author":"Diagnosis","year":"2002","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0253-7613.125159-8","first-page":"109","volume-title":"Summary of the NHLBI Working Group on Research on Hypertension during pregnancy","author":"Roberts","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"key-10.4103\/0253-7613.125159-9","doi-asserted-by":"crossref","unstructured":"Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al., Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet 2002;359:1877-90.","DOI":"10.1016\/S0140-6736(02)08778-0"},{"key":"key-10.4103\/0253-7613.125159-10","first-page":"103","volume-title":"Magnesium sulphate regimens for women with eclampsia: Messages from the Collaborative Eclampsia Trial","author":"Duley","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.4103\/0253-7613.125159-11","first-page":"402","volume-title":"Diagnosis, prevention and management of eclampsia","author":"Sibai","year":"2005","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0253-7613.125159-12","first-page":"181","volume-title":"Drug safety in pregnant women and their babies: Ignorance not bliss","author":"Chambers","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.125159-13","first-page":"941","volume-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: An updated metaregression analysis","author":"von","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"key-10.4103\/0253-7613.125159-14","first-page":"1328","volume-title":"Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?","author":"Grossman","year":"1996","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.125159-15","first-page":"1046","volume-title":"Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy","author":"Brown","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/0253-7613.125159-16","first-page":"1332","volume-title":"Fortnightly review: Management of hypertension in pregnancy","author":"Magee","year":"1999","journal-title":"BMJ"},{"key":"key-10.4103\/0253-7613.125159-17","first-page":"229","volume-title":"Hypertension in gestational diabetes mellitus: Pathophysiology and long-term consequences","author":"Sibai","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.4103\/0253-7613.125159-18","first-page":"835","volume-title":"Imitators of severe pre-eclampsia\/eclampsia","author":"Sibai","year":"2004","journal-title":"Clin Perinatol"},{"key":"key-10.4103\/0253-7613.125159-19","first-page":"1085","volume-title":"Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials","author":"Chien","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"key-10.4103\/0253-7613.125159-20","first-page":"1455","volume-title":"Which anticonvulsant for women with eclampsia.Evidence from the Collaborative Eclampsia Trial?","author":"Eclampsia","year":"1995","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.125159-21","first-page":"907","volume-title":"Maternal morbidity associated with vaginal versus cesarean delivery","author":"Burrows","year":"2004","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/0253-7613.125159-22","first-page":"143","volume-title":"A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery","author":"Bagratee","year":"2001","journal-title":"BJOG"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:23:37Z","timestamp":1786649017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.125159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"alternative-id":["125159"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.125159","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}